DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Celgene (NASDAQ: CELG)

97.89 -4.04 (-3.96%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $97.89 -3.96%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.72
Previous Close $101.93
Daily Range $96.40 - $101.94
52-Week Range $92.98 - $140.72
Market Cap $76.9B
P/E Ratio 21.64
Dividend (Yield) $0.00 (0.0%)
Volume 7,801,969
Average Daily Volume 7,286,012
Current FY EPS $4.19




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

Why Did Biotech Fall Off a Cliff in January?

Biotech's decline doesn't signal the start of a bear market for the industry. Here's why.

ImmunoGen/Merck Collaborate for Ovarian Cancer Study

Leerink Is Back On Board The Biotech Train

See Which Of The Latest 13F Filers Holds Celgene

Synthetic Biologics Tanks on Unfavorable Trimesta Data

Alexion Misses on Earnings and Revenues in Q4, Gives View

Avalanche (AAVL) Set to Acquire Annapurna Therapeutics

Exelixis' Cabozantinib Positive in Renal Cell Carcinoma Study

Why NantKwest Shares Fell 41% in January

Billionaire Patrick Soon-Shiong hopes to change cancer treatment forever.

How to Use a Stock Market Crash to Your Advantage

Stocks are down big since the start of the year, but here's a list of three stocks you can safely buy in the market's carnage.

See More CELG News...

CELG's Top Competitors

CELG $97.89 (-3.96%)
Current stock: CELG
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
$0.00 (0.00%)
Current stock: